Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease ManifestationsNadera Sweiss, Timothy B. Niewold, Kenneth Pursell et al.|PLoS ONE|2010Cited by 140
Ocrelizumab: a step forward in the evolution of B-cell therapyFariha Kausar, Nadera Sweiss, Khader N. Mustafa et al.|Expert Opinion on Biological Therapy|2009Cited by 64
Correction: Significant CD4, CD8, and CD19 Lymphopenia in Peripheral Blood of Sarcoidosis Patients Correlates with Severe Disease ManifestationsNadera Sweiss, Timothy B. Niewold, Joe G. N. Garcia et al.|PLoS ONE|2010Cited by 21